$HCTI

Healthcare Triangle's subsidiary, Purpose Health, secured multiple multi-year contracts in healthcare tech, including EHR optimization, cybersecurity, and IT services for a global tech center. The wins follow its July 2026 launch and include work with a university health system and rural hospitals in three states. CEO Sumit Ganguli highlighted the company's momentum and commitment to AI-led solutions.

Healthcare Triangle, Inc. (HCTI) announced a 1-for-20 reverse stock split to comply with Nasdaq's $1 minimum bid price requirement. The split, effective October 26, 2026, will reduce shares outstanding from 17.7M to 886.5K. The company aims to increase its stock price and regain compliance with Nasdaq's listing rules.

Healthcare Triangle (HCTI) reports six signed AI engagements in its Teyame business, estimated to generate about $4.65M in annual revenue. The deals involve insurance and financial services clients, with starts scheduled for late 2026. An additional unsigned engagement could add $3.31M annually. The company's CFO highlights the combination of AI and sales expertise to enhance customer reach.

Nasdaq notified Healthcare Triangle (HCTI) of a delisting due to noncompliance with the $1.00 minimum bid price rule and prior reverse splits. The company plans to appeal, which would stay the suspension and allow continued trading under HCTI.

Healthcare Triangle (HCTI) signed an MOU with AI World to form a joint venture for AI-enabled humanoid nursing robots in North America. HCTI will hold 70% ownership, leveraging its hospital network. The robots aim to assist with patient hygiene, addressing nursing shortages. The global market for robotic nurse assistants is projected to reach $4.4B by 2033. The venture is subject to due diligence and regulatory approvals.

Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen

Healthcare Triangle (HCTI) signed a non-binding LOI to acquire Roboticom's industrial robotics business. Roboticom's 2025 revenue was $14.1M, with projections of $153.5M by 2029/30. HCTI may pay up to $30M in cash and equity. The deal aims to expand HCTI's tech platform into industrial automation.

Healthcare Triangle (HCTI) partners with Kanzun-ARCB Growth Fund to help Malaysian healthcare companies expand into U.S. markets. HCTI will provide AI, cloud, and data expertise. ARCB brings AED 300M in assets, while Kanzun leads deal sourcing in Malaysia.

Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 2, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into (i) a Separation and Distribution Agreement (the “Separation Agreement”) and (ii) a Transition Services Agreement

Healthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.